Johnson & Johnson’s Erik Haas disputed the Purdue decision's impact, adding that it actually validated the talc plan. In its objection, the U.S. Trustee said it also was investigating ...

A group of claimants who say they developed cancer by using Johnson & Johnson (NYSE:JNJ) talc-based products have asked a judge to reject the healthcare giant's plan to settle lawsuits for ~$8B as ...

Holdout creditors who claim tainted baby powder gave them ovarian cancer urged a judge to reject Johnson & Johnson’s plan to force an end to all related cancer lawsuits. The proposed settlement ...

The agencies' filing did not say how much federal health programs might be owed for providing medical coverage to patients who allege that J&J's baby powder or other talc products contained ...

Julie Whytock, 64, from Hertfordshire, says she developed ovarian cancer after using Johnson & Johnson (J&J) talc powder ‘at least once a day’ as a young child. After her diagnosis with stage ...

The specialty minerals segment, sells calcium carbonate, limestone, and talc, which is used in the paper, building materials, paint, automotive, and pharmaceutical industries. The refractories ...

The specialty minerals segment, sells calcium carbonate, limestone, and talc, which is used in the paper, building materials, paint, automotive, and pharmaceutical industries. The refractories ...

The specialty minerals segment, sells calcium carbonate, limestone, and talc, which is used in the paper, building materials, paint, automotive, and pharmaceutical industries. The refractories ...

A talc plaintiff is seeking a new trial in a Pittsburgh trial that ended in a defense win for Johnson & Johnson. The jury had found for the defense on causation but had incorrectly gone on to ...

Several headwinds are impacting the company, including generic competition for its blockbuster drug Stelara, the ongoing talc lawsuit (which could see a final decision in the first half of the ...